Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients.
Saved in:
| Title: | Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients. |
|---|---|
| Authors: | Goel S; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Frost E; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Tarquinio K; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Kamat P; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Fitch T; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Stenger E; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Liu K; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Qayed M; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., He Z; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Westbrook A; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Williams KM; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Schoettler ML; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Sep 03; Vol. 15, pp. 1642939. Date of Electronic Publication: 2025 Sep 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
